Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution

被引:45
作者
Leaman, Daniel P. [1 ]
Zwick, Michael B. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
来源
PLOS PATHOGENS | 2013年 / 9卷 / 02期
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; HIV-1; ENVELOPE; NEUTRALIZING ANTIBODIES; TYPE-1; GP41; GLYCOPROTEIN TRIMERS; SOLUBLE CD4; V3; LOOP; CONFORMATIONAL-CHANGES; GP120-CD4; BINDING;
D O I
10.1371/journal.ppat.1003184
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The functional HIV-1 envelope glycoprotein (Env) trimer, the target of anti-HIV-1 neutralizing antibodies (Abs), is innately labile and coexists with non-native forms of Env. This lability and heterogeneity in Env has been associated with its tendency to elicit non-neutralizing Abs. Here, we use directed evolution to overcome instability and heterogeneity of a primary Env spike. HIV-1 virions were subjected to iterative cycles of destabilization followed by replication to select for Envs with enhanced stability. Two separate pools of stable Env variants with distinct sequence changes were selected using this method. Clones isolated from these viral pools could withstand heat, denaturants and other destabilizing conditions. Seven mutations in Env were associated with increased trimer stability, primarily in the heptad repeat regions of gp41, but also in V1 of gp120. Combining the seven mutations generated a variant Env with superior homogeneity and stability. This variant spike moreover showed resistance to proteolysis and to dissociation by detergent. Heterogeneity within the functional population of hyper-stable Envs was also reduced, as evidenced by a relative decrease in a proportion of virus that is resistant to the neutralizing Ab, PG9. The latter result may reflect a change in glycans on the stabilized Envs. The stabilizing mutations also increased the proportion of secreted gp140 existing in a trimeric conformation. Finally, several Env-stabilizing substitutions could stabilize Env spikes from HIV-1 clades A, B and C. Spike stabilizing mutations may be useful in the development of Env immunogens that stably retain native, trimeric structure.
引用
收藏
页数:21
相关论文
共 104 条
[1]   Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) [J].
Agrawal, Nitish ;
Leaman, Daniel P. ;
Rowcliffe, Eric ;
Kinkead, Heather ;
Nohria, Raman ;
Akagi, Junya ;
Bauer, Katherine ;
Du, Sean X. ;
Whalen, Robert G. ;
Burton, Dennis R. ;
Zwick, Michael B. .
PLOS ONE, 2011, 6 (06)
[2]   An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120 [J].
Alam, SM ;
Paleos, CA ;
Liao, HX ;
Scearce, R ;
Robinson, J ;
Haynes, BF .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (08) :836-845
[3]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[4]   Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A [J].
Beddows, Simon ;
Kirschner, Marc ;
Campbell-Gardener, Lila ;
Franti, Michael ;
Dey, Antu K. ;
Iyer, Sai Prasad N. ;
Maddon, Paul J. ;
Paluch, Maciej ;
Master, Aditi ;
Overbaugh, Julie ;
VanCott, Thomas ;
Olson, William C. ;
Moore, John P. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (06) :569-579
[5]   Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions [J].
Binley, JM ;
Cayanan, CS ;
Wiley, C ;
Schülke, N ;
Olson, WC ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5678-5684
[6]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643
[7]   Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41 [J].
Blish, Catherine A. ;
Nguyen, Minh-An ;
Overbaugh, Julie .
PLOS MEDICINE, 2008, 5 (01) :90-103
[8]   HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry [J].
Blish, Catherine A. ;
Nedellec, Rebecca ;
Mandaliya, Kishorchandra ;
Mosier, Donald E. ;
Overbaugh, Julie .
AIDS, 2007, 21 (06) :693-702
[9]   Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution [J].
Bontjer, Ilja ;
Melchers, Mark ;
Eggink, Dirk ;
David, Kathryn ;
Moore, John P. ;
Berkhout, Ben ;
Sanders, Rogier W. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (47) :36456-36470
[10]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION [J].
BUCHACHER, A ;
PREDL, R ;
STRUTZENBERGER, K ;
STEINFELLNER, W ;
TRKOLA, A ;
PURTSCHER, M ;
GRUBER, G ;
TAUER, C ;
STEINDL, F ;
JUNGBAUER, A ;
KATINGER, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :359-369